News
What's happening in Alzheimer's care, research funding, and treatment — summarized simply, each item linked to the original reporting.
Free to read, “May need a subscription” and “Archived copy”: what they mean
Whether an article is free to read is a guess, not a test of your access. Each item is one of three:
- No label: free to read (304 of 349). The publisher’s page marks it free, or the outlet publishes free to read: Medical Xpress, ScienceDaily, NIH (incl. NIA and PMC), Alzheimer's Association, Alzheimer's News Today, NPR, Alzheimer's Disease International, or a .gov site.
- May need a subscription (11 of 349). The publisher’s own page marks the article as not free to read, or — when the page says nothing — the outlet sells subscriptions: The New York Times, STAT, Scientific American, The Washington Post, The Wall Street Journal, Financial Times, The Economist, Bloomberg, The Atlantic, The New Yorker, Wired, Los Angeles Times, The Boston Globe, The Times, The Telegraph, New Scientist, Endpoints News, Science. Each badge says which.
- “Free to read? Not known” (34 of 349). The outlet is on neither list and its page said nothing. We do not call these paywalled.
Archived copy links go to a copy the Internet Archive (web.archive.org) saved, dated the day it was saved. We show one only where the Internet Archive reported a working saved copy when we checked; an archived copy of a subscription article sometimes shows only its opening. 265 of 349 items have one.
Added antibody step improves the reliability of Alzheimer's blood tests
Researchers at University Medicine Halle have developed a new method that could improve the reliability of blood tests for Alzheimer's disease. Current commercial tests often rely on the protein biomarker p-tau217, whose levels can rise in the early stages of the disease. …
Read at Medical Xpress →More education reduces dementia risk decades later
A law that required British teenagers to stay in school for an additional year had an unexpected consequence nearly 50 years later: fewer dementia diagnoses.
Read at Medical Xpress →New microscopy technology may help detect neurological diseases before neurons die
Scientists studying amyotrophic lateral sclerosis (ALS), Parkinson's, Alzheimer's and other neurological diseases are getting unprecedented views inside brain cells, using powerful new microscopes to uncover changes that may begin long before neurons die. …
Read at Medical Xpress →Two-step blood-test approach helps clarify uncertain brain amyloid status
Blood-based biomarkers (BBMs) are blood tests that can detect Alzheimer's disease (AD) brain changes earlier, more cheaply and more easily than traditional methods such as Aβ-PET scans, which are expensive and have limited accessibility. …
Read at Medical Xpress →Search for Alzheimer's drug unexpectedly finds possible biomarker
Researchers developed a drug for Alzheimer's disease and then discovered that the molecule already exists in human blood and is found at lower levels in cognitively impaired people. Now the authors are exploring the peptide as a biomarker as well as a treatment.
Read at Medical Xpress →Fitness tracker data could offer clues about future brain health
Adults who averaged fewer than 5,000 steps a day were later diagnosed with dementia, Parkinson's disease or stroke at almost twice the rate of those averaging more than 12,000 steps…
Read at Medical Xpress → Archived copy (23 Oct 2026), Internet ArchiveGut microbiome could help identify people at risk of dementia
In what is thought to be the first study of its kind, researchers from Cardiff University and Imperial College London examined both gut bacteria and chemicals. Their findings could support earlier diagnosis and help spot people at risk of faster decline.
Read at Medical Xpress → Archived copy (20 Oct 2026), Internet ArchiveBrain PET scans help select and monitor patients for new Alzheimer's drugs
Nuclear medicine is playing an increasingly important role in the diagnosis and treatment of Alzheimer's disease, helping clinicians visualize the biological changes associated with the condition and guide decisions about new therapies. …
Read at Medical Xpress →Visual processing tests could help diagnose some common forms of dementia
The dementia associated with Parkinson's disease could be diagnosed earlier with new visual tests developed by University of Queensland researchers. …
Read at Medical Xpress → Archived copy (15 Oct 2026), Internet ArchiveAlzheimer's blood biomarker tracks brain amyloid similarly across racial groups, study finds
A large global study provides new evidence supporting the use of blood biomarkers in an Alzheimer's clinical trial to screen for elevated brain amyloid levels among potential participants who are cognitively unimpaired. …
Read at Medical Xpress → Archived copy (13 Oct 2026), Internet ArchiveEarly-onset Alzheimer's disease shows different warning signs from established risk factors
A study by the University of Oulu and the University of Eastern Finland found that people who developed Alzheimer's disease before the age of 65 accumulated a wide range of health problems, particularly during the five years preceding diagnosis. …
Read at Medical Xpress → Archived copy (11 Oct 2026), Internet ArchiveImproving early detection of cognitive impairment in primary care
Early detection of cognitive impairment can connect patients with evaluation and treatment sooner, but many screening methods are difficult to incorporate into routine primary care. …
Read at Medical Xpress → Archived copy (7 Oct 2026), Internet ArchiveObesity's link to lower risk of death in dementia points to likely importance of nutrition
People who are overweight or obese when they are diagnosed with dementia are likely to live longer than those in a normal weight range, according to a new study by Columbia University Mailman School of Public Health and NYU School of Global Public Health. …
Read at Medical Xpress → Archived copy (7 Oct 2026), Internet ArchiveResearchers explore new diagnostic tools, genetic roots for early-onset dementia
Researchers at the new Center for Brain Health at UT Health San Antonio are studying midlife testing for early-onset dementia with blood-based biomarkers to see if they can detect disease activity up to 20 years before symptoms appear.
Why it matters: Midlife blood-based biomarker testing is being studied to see if it can detect early-onset dementia activity up to 20 years before symptoms appear.
Read at Medical Xpress → Archived copy (27 Jan 2026), Internet ArchiveA simple blood test could change how Alzheimer's is diagnosed
A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect Alzheimer's disease at its very earliest stage, even before symptoms appear.
Why it matters: Combining a blood test with an ultrathin graphite-derived material could advance efforts to detect Alzheimer's disease before symptoms appear.
Read at Medical Xpress →Study finds ongoing under-diagnosis of high blood pressure in people over 50 in Ireland
High blood pressure becomes more common after age 40, yet new research from The Irish Longitudinal Study on Ageing (TILDA) at Trinity College Dublin shows that many people in Ireland with hypertension are still not optimally diagnosed or treated based on European Guidelines. …
Why it matters: New research shows many people over 50 in Ireland with high blood pressure are still not optimally diagnosed or treated based on European Guidelines.
Read at Medical Xpress → Archived copy (4 Feb 2026), Internet ArchivePlasma p-tau217 can reliably detect preclinical Alzheimer disease
Plasma phosphorylated tau 217 (p-tau217) can reliably detect Alzheimer disease (AD) pathology in the preclinical stage, according to a meta-analysis published online Dec. 1 in JAMA Neurology.
Why it matters: Plasma phosphorylated tau 217 can reliably detect Alzheimer disease pathology in the preclinical stage, according to a meta-analysis.
New AI technology can provide rapid and reliable dementia diagnosis
Researchers at Örebro University have developed two new AI models that can analyze the brain's electrical activity and accurately distinguish between healthy individuals and patients with dementia, including Alzheimer's disease.
Why it matters: Researchers developed AI models analyzing brain electrical activity to distinguish healthy individuals from dementia and Alzheimer's patients.
New method to track progression of Alzheimer's, related dementias based on metabolic, vascular brain changes
Researchers from the Indiana University School of Medicine have developed a highly sensitive diagnostic that predicts a person's stage of dementia based on neurovascular and metabolic changes. They recently published their findings in Alzheimer's & Dementia.
Why it matters: Indiana University researchers developed a highly sensitive diagnostic predicting dementia stages based on neurovascular and metabolic changes.
Follow new items in a feed reader: Atom feed.